HN-Cell and Gene Therapies

Ensuring Product Safety

Adopt a safety-first approach C&GT product manufacturers face a major challenge in making sure their products are completely free from any harmful contaminants. SGS provide a range of services to address this critical safety issue, including:

• Bioburden and sterility analysis • Quantitation of endotoxin • Biosafety Testing. Detection and identification of adventitious agents • Characterisation of plasmid starting materials for vector production • Cell therapy characterisation and ICHQ5A / USP / Phar. Eur biosafety testing

SGS will work tirelessly to ensure that when you do bring a product to market, it is safe. Rest easy in the knowledge that you can focus on your core business activity while the experts at SGS leverage their broad analytical portfolio and unparalleled knowledge to safeguard the quality of the final product.

Made with FlippingBook - Share PDF online